MedinCell S.A.

EPA:MEDCL.PA

16.3 (EUR) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Revenue 2.0476.9853.8626.0272.4871.6036.961.2260.8951.9572.2461.1231.8010.9015.5932.7972.7081.354
Cost of Revenue 0-1.195-2.084-1.682-1.772-2.4761.92-1.92-1.196-1.9520.0010.0010.0780.0390.1850.0930.0330.017
Gross Profit 2.0478.185.9467.7094.2594.0795.043.1462.0913.9092.2451.1231.7230.8625.4082.7042.6751.338
Gross Profit Ratio 11.1711.541.2791.7132.5450.7242.5662.3361.997110.9570.9570.9670.9670.9880.988
Reseach & Development Expenses 9.28810.50712.57814.08811.81210.62811.5067.0218.7257.4797.1383.5694.8372.4194.9932.4973.9371.969
General & Administrative Expenses 04.5863.8383.293.2362.9782.9512.692.9532.6462.5271.2642.3721.1862.2691.1351.9770.989
Selling & Marketing Expenses 01.4091.281.3081.1661.1061.0390.7581.1211.2411.5050.7531.1710.5861.0050.5020.8830.442
SG&A 5.6225.7764.9364.4594.2544.0263.9353.4253.7953.9654.0322.0163.5431.7723.2741.6372.861.43
Other Expenses 000000000000000000
Operating Expenses 14.9116.28317.51418.54716.06614.65415.44110.44612.5211.44411.0365.51810.6065.3038.8994.456.6073.304
Operating Income -13.716-10.164-14.478-13.359-14.378-13.768-8.941-10.1-12.312-10.056-8.89-4.445-6.617-3.309-2.858-1.429-4.109-2.055
Operating Income Ratio -6.701-1.455-3.749-2.217-5.781-8.589-1.285-8.238-13.756-5.138-3.958-3.958-3.674-3.674-0.511-0.511-1.517-1.517
Total Other Income Expenses Net -4.7940.811-5.869-2.07-0.434-0.473-0.994-2.574-1.385-0.837-0.956-0.478-3.247-1.624-1.534-0.767-0.714-0.357
Income Before Tax -18.51-9.353-20.347-15.429-14.812-14.241-9.935-12.674-13.697-10.893-9.846-4.923-9.864-4.932-4.392-2.196-4.823-2.412
Income Before Tax Ratio -9.043-1.339-5.269-2.56-5.956-8.884-1.427-10.338-15.304-5.566-4.384-4.384-5.477-5.477-0.785-0.785-1.781-1.781
Income Tax Expense -1.63-1.195-2.084-1.682-1.764-2.483-1.669-1.921.22-1.8950.0060.0030.0340.0170.320.160.040.02
Net Income -16.88-8.158-18.263-13.747-13.048-11.758-8.266-10.754-14.916-8.999-9.857-4.929-9.83-4.915-4.708-2.354-4.863-2.432
Net Income Ratio -8.246-1.168-4.729-2.281-5.246-7.335-1.188-8.772-16.666-4.598-4.389-4.389-5.458-5.458-0.842-0.842-1.796-1.796
EPS -0.58-0.29-0.72-0.55-0.52-0.47-0.33-0.5-0.74-0.45-0.49-0.25-0.68-0.34-0.33-0.16-0.34-0.17
EPS Diluted -0.58-0.29-0.72-0.55-0.52-0.47-0.33-0.5-0.74-0.45-0.49-0.25-0.68-0.34-0.33-0.16-0.34-0.17
EBITDA -12.863-9.298-13.652-12.52-13.579-13.051-8.481-9.22-11.625-9.487-8.658-4.329-6.255-3.128-2.688-1.344-3.786-1.893
EBITDA Ratio -6.284-1.331-3.535-2.077-5.46-8.142-1.219-7.52-12.989-4.848-3.855-3.855-3.473-3.473-0.481-0.481-1.398-1.398